These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6143969

  • 1. BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
    Gresele P, Deckmyn H, Arnout J, Lemmens J, Janssens W, Vermylen J.
    Lancet; 1984 May 05; 1(8384):991-4. PubMed ID: 6143969
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H, Stegmeier K, Müller-Beckmann B, Sponer G, Staiger C, Neugebauer G.
    Biomed Biochim Acta; 1984 May 05; 43(8-9):S312-8. PubMed ID: 6097235
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients.
    Riess H, Höfling B, von Arnim T, Hiller E.
    Thromb Res; 1986 Apr 15; 42(2):235-45. PubMed ID: 3012819
    [Abstract] [Full Text] [Related]

  • 4. Antiaggregatory effects of thromboxane receptor antagonists in vivo.
    Darius H, Lefer AM.
    Thromb Res; 1985 Dec 01; 40(5):663-75. PubMed ID: 2935972
    [Abstract] [Full Text] [Related]

  • 5. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M, De Cunto M, Parise P, Grasselli S, Nenci GG.
    Eur J Clin Pharmacol; 1990 Dec 01; 39(5):495-500. PubMed ID: 1963845
    [Abstract] [Full Text] [Related]

  • 6. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

  • 7. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep 01; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 8. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
    Swann PG, Venton DL, Le Breton GC.
    FEBS Lett; 1989 Jan 30; 243(2):244-6. PubMed ID: 2537230
    [Abstract] [Full Text] [Related]

  • 9. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T, Hashizume T, Nakao K, Akiba S, Fujii T.
    Biochim Biophys Acta; 1989 Aug 18; 992(2):168-73. PubMed ID: 2503041
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S, Whittle BJ.
    Br J Pharmacol; 1986 Aug 18; 88(4):931-6. PubMed ID: 3017497
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May 18; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 12. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J, McGiff JC, Nasjletti A.
    Br J Pharmacol; 1989 Jan 18; 96(1):111-6. PubMed ID: 2522332
    [Abstract] [Full Text] [Related]

  • 13. On the mechanism of the prolonged action in man of GR32191, a thromboxane receptor antagonist.
    Ritter JM, Doktor HS, Benjamin N, Barrow SE, Stewart-Long P.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Jan 18; 21A():351-4. PubMed ID: 1825568
    [Abstract] [Full Text] [Related]

  • 14. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H, Yanagisawa A, Lefer AM.
    Circ Shock; 1986 Jan 18; 20(1):1-11. PubMed ID: 2945667
    [Abstract] [Full Text] [Related]

  • 15. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
    Vargaftig B, Joseph D, Hatmi M.
    Thromb Res; 1987 May 15; 46(4):509-17. PubMed ID: 3039684
    [Abstract] [Full Text] [Related]

  • 16. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P, White BP, Humphrey PP.
    Br J Pharmacol; 1989 Jul 15; 97(3):783-94. PubMed ID: 2527074
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.